EDGAR Filing Documents for 0001564590-15-009954

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-15-009954

Filing Date

2015-11-06

Accepted

2015-11-06 16:49:25

Documents

Period of Report

2015-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	cnat-10q_20150930.htm	10-Q	902044
2	EX-31.1	cnat-ex311_6.htm	EX-31.1	10757
3	EX-31.2	cnat-ex312_7.htm	EX-31.2	11934
4	EX-32.1	cnat-ex321_8.htm	EX-32.1	6597
5	EX-32.2	cnat-ex322_9.htm	EX-32.2	7464
	Complete submission text file	0001564590-15-009954.txt		3429742

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	cnat-20150930.xml	EX-101.INS	699989
7	XBRL TAXONOMY EXTENSION SCHEMA	cnat-20150930.xsd	EX-101.SCH	23204
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	cnat-20150930_cal.xml	EX-101.CAL	31180
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	cnat-20150930_def.xml	EX-101.DEF	67499
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	cnat-20150930_lab.xml	EX-101.LAB	213796
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	cnat-20150930_pre.xml	EX-101.PRE	156427

Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127

Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600

Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)